Millennium Adopts Bioscale's ViBE Platform as Part of its Drug Development Workflow

The drugmaker, which purchased a system in August after several months of trying out a beta version, is using it to measure pharmacodynamic biomarkers, and has found it cuts run times for such assays from a week down to as little as a day.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.